Skip to content
navbar-toggler
Home
About
Lumira Ventures
Our Values
Foundation
Team
Our Team
Venture Fellows
Portfolio
Stories
News
Login
Proactive Care, Heartfelt Impact—
Advancing Heart Failure Management at Home.
Cardiovascular Disease Shouldn't Go Undetected For Women.
More Accurate Solutions For Life-Saving Care.
Coronary Artery Disease Diagnosed And Treated
- Now With Confidence.
Active Epileptic Seizures Can Now
Be Terminated On Demand.
Lupus Nephritis Can Be Devastating.
LUPKYNIS™ - Reducing The Need For Kidney Transplants.
Disruptive Cancer Therapies -
Made To Make A Difference.
Chemotherapy Without Destroying Your Immune System?
COSELA® (trilaciclib) Has It Conquered.
No Longer A Chronic Life-Long Disease -
Hepatitis C Cured.
Robotic Joint Replacement Surgery -
Less Invasive, Highly Successful.
Performance is More Than Just Great Returns To Our Investors.
It Is Also Measured By Impact.
40+ Diseases Targeted
35+ Approved Products
$75+ Billion Cumulative Revenue from Approved Products
Over 5 Million Patients Treated
$6+ Billion Capital Raised by Portfolio Companies
Toronto (Head Office)
141 Adelaide Street Suite 770 Toronto, ON Canada, M5H 3L5
Montréal
Espace CDPQ 3, Place Ville Marie Bureau 12350, Niveau L Montreal, QC Canada, H3B 0E7
Vancouver
Vancouver, BC Canada
Boston
303 Wyman Street Suite 300 Waltham, MA, USA, 02451-1208
Scroll to Top